HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A Metodieva Selected Research

PF-114

5/2015PF-114, a potent and selective inhibitor of native and mutated BCR/ABL is active against Philadelphia chromosome-positive (Ph+) leukemias harboring the T315I mutation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


A Metodieva Research Topics

Disease

1Leukemia
05/2015
1Philadelphia Chromosome
05/2015

Drug/Important Bio-Agent (IBA)

1PF-114IBA
05/2015
1ponatinibIBA
05/2015
1Tyrosine Kinase InhibitorsIBA
05/2015